Pure Monograph vs Citeline
Citeline sells pipeline and clinical intelligence data. Pure Monograph assembles source-traced reports from public evidence. The overlap is narrow and sits on the intelligence-brief side — Citeline feeds data, Pure Monograph produces the case.
Short answer. Citeline (Norstella) is a data business: Pharmaprojects, Trialtrove, Scrip, Pink Sheet. Pure Monograph is enterprise pharmaceutical intelligence: asset intelligence, Trial Autopsy, Trial Counterfactual. If you need curated pipeline data, buy Citeline. If you need the scientific case assembled, use Pure Monograph.
At a glance
| Dimension | Pure Monograph | Citeline (Norstella) |
|---|---|---|
| Primary deliverable | Source-traced monographs, trial analysis, intelligence briefs | Pipeline, trial, and regulatory intelligence databases + editorial news |
| Category | Molecule intelligence | Data + editorial subscriptions |
| Products / surfaces | Asset intelligence, Trial Autopsy, Trial Counterfactual | Pharmaprojects (pipeline), Trialtrove (clinical trials), Scrip (news), Pink Sheet (regulatory news) |
| Regulatory output | Cited reports with gaps marked; not a submission publisher | Not an authoring tool |
| Pricing | Free: one named-molecule report. No upload. Enterprise: team workspace. | Enterprise database subscriptions |
| Engagement model | Self-serve report, then ask us for a team workspace | Multi-year data license |
| Ownership | Burrard Pharmaceutical Enterprises Ltd., Vancouver BC | Owned by Norstella (private equity portfolio) |
Where each wins
Citeline wins when you need an authoritative, continuously-curated view of competitor pipelines, clinical trial phases, or regulatory news as a data feed. Teams that maintain tracker dashboards, deal-flow models, or landscape monitoring are buying the data itself.
Pure Monograph wins when you need to do something with that landscape: brief an exec on competitor threat, take a trial apart, or assemble the scientific case for a molecule with gaps marked.
Using them together
Sponsors that license Citeline and use Pure Monograph typically keep Citeline as the data feed and Pure Monograph as the analysis layer. Pure Monograph does not ingest Citeline data without authorization; it produces original synthesis from explicit inputs or open data sources.
Frequently asked questions
What is Citeline?
Citeline is a Norstella-owned pipeline and clinical intelligence business covering Pharmaprojects, Trialtrove, Scrip, and Pink Sheet. It sells curated databases and editorial coverage.
Does Pure Monograph compete with Citeline?
Partly. Pure Monograph produces intelligence briefs that overlap with the questions Citeline data answers, but Pure Monograph is a source-traced analysis layer, not a curated database.
Can I use both?
Yes. Citeline is the source-of-truth data; Pure Monograph synthesizes public evidence into source-traced reports and executive briefs.
Do you license Citeline data?
No. Pure Monograph does not redistribute Citeline data. If you already license Citeline, briefs can be grounded against your own exports during an engagement.